SWOG Network Group Operations Center of the NCTN

NCTN SWOG 网络集团运营中心

• 批准号: 8605343
• 负责人: CHARLES D. BLANKE
• 金额: $ 1382.91万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8605343
• 关键词: Accountability; Address; Adolescent; Adult; Advisory Committees; Advocate; Anatomy; Applications Grants; Behavior; Canada; Categories; Clinical; Clinical Sciences; Clinical Trials; Clinical Trials Network; Collaborations; Communication; Communities; Complement; Conduct Clinical Trials; Data Reporting; Development; Disease; Ensure; Ethics; Fostering; Foundations; Funding; Generations; Goals; Histologic; International; Korea; Latin America; Lead; Leadership; Malignant Neoplasms; Mentors; Mission; Monitor; Participant; Pathway interactions; Patient advocacy; Patients; Policies; Prevention; Principal Investigator; Process; Program Development; Quality of life; Recording of previous events; Reporting; Research; Research Personnel; Resources; Running; Safety; Saudi Arabia; Science; Scientist; Site; Southwest Oncology Group; Speed; Structure; Training Support; United States Food and Drug Administration; Work; anticancer research; cancer therapy; design; improved; innovation; international center; meetings; member; neoplastic; operation; programs; public health relevance; research study; survivorship; tool; translational clinical trial; translational medicine; translational study; working group; young adult

DESCRIPTION (provided by applicant): SWOG is a research organization with cancer investigators distributed across 550 academic and community sites throughout the U.S. Canada, Latin America, Korea, and Saudi Arabia. The Group has a long history of conducting clinical trials that have changed standard of oncologic practice and that have led to Food and Drug Administration approval of new anti-neoplastic agents. SWOG's mission is to design, direct and participate in clinical trials that will result in effective prevention and treatment of cancer in the process improving quality of life and quality of survivorship for those with malignancies. Guiding principles used to help achieve these goals include placing patients as our highest priority, using the best science to drive our research, embracing diversity in membership and leadership, demanding ethical behavior, and fostering young investigators. SWOG's specific aims for this application include Improving efficiency and rapidly executing the clinical trial development and conduct processes; collaborating widely to reduce accrual barriers and facilitate participation in NCTN trials; maximizing potential from international partners by studying globally-significant cancers; and being active participants and leaders in NCTN management. Building on our successful past while significantly moving forward, SWOG will be a clinical trials organization dedicated to conducting high-value, high-impact cancer trials.

描述（由申请人提供）：SWOG是一个研究组织，癌症研究人员分布在美国、加拿大、拉丁美洲、韩国和沙特阿拉伯的550个学术和社区站点。该集团在进行临床试验方面有着悠久的历史，这些试验改变了肿瘤学实践的标准，并导致美国食品和药物管理局批准了新的抗肿瘤药物。SWOG的使命是设计、指导和参与临床试验，从而有效预防和治疗癌症，提高恶性肿瘤患者的生活质量和生存质量。用于帮助实现这些目标的指导原则包括将患者作为我们的最高优先事项，使用最好的科学来推动我们的研究，拥抱成员和领导的多样性，要求道德行为，以及培养年轻的研究人员。SWOG的具体目标包括提高效率，快速执行临床试验开发和实施流程;广泛合作，减少应计障碍，促进参与NCTN试验;通过研究全球重大癌症，最大限度地发挥国际合作伙伴的潜力;并积极参与和领导NCTN管理。在我们成功的过去的基础上，SWOG将成为一个致力于开展高价值、高影响力癌症试验的临床试验组织。